Log in
NYSEARCA:VUSE

Vident Core U.S. Equity Fund Stock Forecast, Price & News

$30.68
+0.06 (+0.20 %)
(As of 10/23/2020 12:00 AM ET)
Add
Today's Range
$30.51
Now: $30.68
$30.72
50-Day Range
$27.93
MA: $29.60
$30.97
52-Week Range
$18.99
Now: $30.68
$33.80
Volume31,042 shs
Average Volume56,118 shs
Market Capitalization$331.31 million
P/E RatioN/A
Dividend Yield1.51%
BetaN/A

Geographic Exposure of VUSE

Currency Exposure of VUSE

Sector Exposure of VUSE

Industry Exposure of VUSE

Basic Details

Issuer Vident Financial
Fund NameVident Core U.S. Equity Fund
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:VUSE
Inception Date1/21/2014
Fund ManagerDenise M. Krisko
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkVIUSX Index
CategoryBroad Equity
FocusBroad Equity
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$334.09 million
Average Daily Volume$16,617.40
Discount/Premium0.00%

ETF Expenses

Management Fee0.50%
Other Expenses0.00%
Total Expenses0.50%
Fee Waiver-0.02%
Net Expenses0.48%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorExchange Traded Concepts, LLC
CustodianU.S. Bank, N.A.
DistributorQuasar Distributors, LLC
Transfer AgentU.S. Bank, N.A.
Trustee
Lead Market MakerVirtu Financial
$30.68
+0.06 (+0.20 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VUSE News and Ratings via Email

Sign-up to receive the latest news and ratings for VUSE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Vident Core U.S. Equity Fund (NYSEARCA:VUSE) Frequently Asked Questions

How has Vident Core U.S. Equity Fund's stock been impacted by Coronavirus?

Vident Core U.S. Equity Fund's stock was trading at $25.16 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, VUSE stock has increased by 21.9% and is now trading at $30.6766.
View which stocks have been most impacted by COVID-19
.

How often does Vident Core U.S. Equity Fund pay dividends? What is the dividend yield for Vident Core U.S. Equity Fund?

Vident Core U.S. Equity Fund declared a quarterly dividend on Tuesday, March 17th. Shareholders of record on Wednesday, March 18th will be given a dividend of $0.0792 per share on Thursday, March 19th. This represents a $0.32 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date is Tuesday, March 17th.
View Vident Core U.S. Equity Fund's dividend history
.

What other stocks do shareholders of Vident Core U.S. Equity Fund own?

What is Vident Core U.S. Equity Fund's stock symbol?

Vident Core U.S. Equity Fund trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "VUSE."

Who are Vident Core U.S. Equity Fund's major shareholders?

Vident Core U.S. Equity Fund's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Insight Wealth Partners LLC (0.58%) and Dfpg Investments LLC (0.06%).

Which major investors are selling Vident Core U.S. Equity Fund stock?

VUSE stock was sold by a variety of institutional investors in the last quarter, including Insight Wealth Partners LLC.

Which major investors are buying Vident Core U.S. Equity Fund stock?

VUSE stock was acquired by a variety of institutional investors in the last quarter, including Dfpg Investments LLC.

How do I buy shares of Vident Core U.S. Equity Fund?

Shares of VUSE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vident Core U.S. Equity Fund's stock price today?

One share of VUSE stock can currently be purchased for approximately $30.68.

How big of a company is Vident Core U.S. Equity Fund?

Vident Core U.S. Equity Fund has a market capitalization of $331.31 million.

This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.